Safety and tolerability of subcutaneous immunoglobulin 20% in primary immunodeficiency diseases from two continents.
暂无分享,去创建一个
Sudhir Gupta | P. M. van Hagen | M. Stein | G. Kriván | S. Jolles | W. Engl | D. Suez | L. Yel | K. Paris | H. Leibl | N. Brodszki | B. McCoy